SCREENING FOR POTENTIAL SERUM PROTEIN BIOMARKERS IN HEPATOCELLULAR CARCINOMA BY MALDI-TOF/TOF MS AND VALIDATION OF CLUSTERIN IN CELLS AND TISSUES

被引:0
|
作者
Li, Yin [1 ]
Luo, Rong [2 ]
Li, Cuiping [1 ]
Zang, Ning [2 ]
Yang, Xiaoli [2 ]
Li, Gang [2 ]
Zhang, Qinle [2 ]
Liao, Ming [2 ]
He, Xiao [1 ]
Li, Hongtao [2 ]
He, Min [1 ,2 ]
机构
[1] Guangxi Med Univ, Sch Publ Hlth, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Minist Educ, Key Lab High Incidence Tumor Prevent & Treatment, Nanning 530021, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
105
引用
收藏
页码:S54 / S55
页数:2
相关论文
共 50 条
  • [1] SCREENING FOR POTENTIAL SERUM PROTEIN BIOMARKERS IN HEPATOCELLULAR CARCINOMA BY MALDI-TOF/TOF MS AND VALIDATION OF CLUSTERIN IN CELLS AND TISSUES
    Li, Yin
    Luo, Rong
    Li, Cui P.
    Zang, Ning
    Yang, Xiao L.
    Li, Gang
    Zhang, Qin L.
    Liao, Ming
    He, Xiao
    Li, Hong T.
    He, Min
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (03) : 585 - 585
  • [2] Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS
    Chen, Xiao-Li
    Zhou, Le
    Yang, Jun
    Shen, Fu-Kun
    Zhao, Shi-Ping
    Wang, Yi-Li
    MOLECULAR MEDICINE REPORTS, 2010, 3 (04) : 589 - 596
  • [3] MALDI-TOF MS analysis of hepatocellular carcinoma proteome.
    Kim, HJ
    Song, JS
    Park, SJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U130 - U131
  • [4] MALDI-TOF analysis of serum peptides associated with hepatocellular carcinoma
    Goldman, R
    An, Y
    Liao, J
    Orvisky, E
    Ressom, HW
    Varghese, SA
    Goldman, L
    Drake, SK
    Hortin, GL
    Loffredo, CA
    Abdel-Hamid, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (02) : 409 - 409
  • [5] MALDI-TOF MS Combined With Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment of Boosting Decision Tree Model for Diagnosis of Hepatocellular Carcinoma
    Liu, Chibo
    Shen, Jianmin
    Pan, Chunqin
    Yang, Linjun
    Mou, Sihua
    Wang, Haibao
    Liang, Yong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (02) : 235 - 241
  • [6] Proteomic analysis of serum biomarkers in patients with nonalcoholic steatohepatitis using SELDI-TOF/MS or MALDI-TOF/MS
    Uto, Hirofumi
    Sato, Yuko
    Ishida, Yoichi
    Takami, Yoichiro
    Kanmura, Shuji
    Moriuchi, Akihiro
    Hasegawa, Susumu
    Oketani, Makoto
    Ido, Akio
    Nakajima, Tomoaki
    Okanoue, Takeshi
    Tsubouchi, Horohito
    HEPATOLOGY, 2007, 46 (04) : 735A - 736A
  • [7] Optimization of an automated analysis of serum peptides for identification of biomarkers by MALDI-TOF MS
    Liao, Jay J.
    An, Yanming
    Drake, Steve
    Hortin, Glenn
    Ressom, Habtom
    Varghese, Rency
    Loffredo, Chris
    Abdel-Hamid, Mohamed
    Goldman, Radoslav
    CANCER RESEARCH, 2006, 66 (08)
  • [8] Urinary phospholipids by Maldi-Tof/Ms analyses are potential biomarkers for prostate cancer
    Li, X.
    Nakayama, K.
    Goto, T.
    Akamatsu, S.
    Shimizu, K.
    Ogawa, O.
    Inoue, T.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 186 - 186
  • [9] Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS
    Meng, Qiutao
    Ge, Siqi
    Yan, Wenhua
    Li, Ruisheng
    Dou, Jingtao
    Wang, Haibing
    Wang, Baoan
    Ma, Qingwei
    Zhou, Yong
    Song, Manshu
    Yu, Xinwei
    Wang, Hao
    Yang, Xinghua
    Liu, Fen
    Alzain, Mohamed Ali
    Yan, Yuxiang
    Zhang, Ling
    Wu, Lijuan
    Zhao, Feifei
    He, Yan
    Guo, Xiuhua
    Chen, Feng
    Xu, Weizhuo
    Garcia, Monique
    Menon, Desmond
    Wang, Youxin
    Mu, Yiming
    Wang, Wei
    PROTEOMICS CLINICAL APPLICATIONS, 2017, 11 (3-4)
  • [10] Computational methods for MALDI-TOF MS data analysis and their application for discovering peptide and glycan biomarkers of hepatocellular carcinoma
    Ressom, Habtom W.
    Varghese, Rency S.
    Goldman, Lenka
    An, Yanming
    Loffredo, Christopher A.
    Abdel-Hamid, Mohamed
    Kyselova, Zuzana
    Mechret, Yehia
    Novotny, Milos
    Drake, Steven K.
    Goldman, Radoslav
    CANCER BIOMARKERS, 2008, 4 (03) : 158 - 159